National Health Data Systems, Inc. – Trademark Portfolio
Entity Type: 03
National Health Data Systems, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REVEALMYWAY. The owner is based in Croton On Hudson, NY.
130 Hastings Ave.
Croton On Hudson, NY 10520
Showing of trademarks Trademarks
Trademark Classifications
National Health Data Systems, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does National Health Data Systems, Inc. have?
National Health Data Systems, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does National Health Data Systems, Inc. file in?
National Health Data Systems, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are National Health Data Systems, Inc.'s most well-known trademarks?
National Health Data Systems, Inc.'s registered trademark portfolio includes well-known marks such as REVEALMYWAY. These are among 1 currently registered trademark in the portfolio.
What is National Health Data Systems, Inc.'s trademark registration success rate?
National Health Data Systems, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.